Podcasts about mhs

The Mendota boys soccer team has been on a legendary run the last few seasons. The Trojans took it a step further last year taking third at the IHSA Class 1A State Tournament. This year, Mendota has a 20-4 record after a Class 1A Mendota Regional Semifinal victory and is looking to accomplish the goal of winning Mendota High School's first state championship...in any sport. Edge of Your Seat Podcast has been working on this show for a long time, so there a mix of different chats in different time frames. Enjoy!On the show:Sebastian Carlos, now a senior, from his freshman year (11:16.5)Putting in the Work, girls tennis sectionals and boys soccer regionals (16:56)From last year's state tournament: MHS pep rally (25:21.5); semifinal loss post match conference (29:11.5); third-place match victory post match conference (33:33.5)Johan Cortez, summer between the tournament and his senior year (44:30)Outside of the Valley, NBA and NHL have started, World Series begins Friday, NFL is in Week 8, A'ja Wilson is the best in the WNBA (54:44)MHS boys soccer coach Nick Myers, in the summer between the tournament and this season (1:09:35) Myers after the first ever Three Rivers Conference Tournament in early October (1:17:30.5)Cortez and Cesar Casas after the regional semifinal win on Wednesday, Oct. 23 (1:30:42)

This week on the KORE Women Podcast, Dr. Summer Watson welcomes Sheryl Green, who is the “How to Say No” Expert and author of “You Had Me at ‘No: How Setting Healthy Boundaries Helps You Banish Burnout, Repair Relationships, and Save Your Sanity.” After a lifetime of putting everyone else first, Sheryl hit a wall and found her way out through boundaries. Now, she teaches others how to reclaim their energy, repair their relationships, and say NO with confidence. We talk about the PEC framework, navigating guilt, and what happens when you stop apologizing for taking up space. You can follow Sheryl Green on LinkedIn, On Instagram and YouTube at: SherylGreenSpeaks, and Facebook at: You Had Me At No and you can find her book, “You Had Me at No: How Setting Healthy Boundaries Helps You Banish Burnout, Repair Relationships, and Save Your Sanity” on Amazon. Socials:  https://www.linkedin.com/in/sherylgreen/ https://www.instagram.com/sherylgreenspeaks/ https://www.facebook.com/youhadmeatno https://www.youtube.com/@sherylgreenspeaks Book Link for Amazon: https://amzn.to/44mZC4h Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, Google Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast.  Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook.  You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, and her KORE Business Solutions and Cross-Generational Consultation Services by going to: www.korewomen.com. Thank you for listening! Please share this podcast with your family and friends. #HealthyBoundaries #PeoplePleaserRecovery #SayNoWithConfidence #EmotionalWellbeing

10-17-25 MHS 54-MR 22 by MBC Grand, Inc.

This week on the KORE Women Podcast, Dr. Summer Watson welcomes Helen St. Pierre, who is the founder of Old Dogs Go To Helen and author of Old Dog, New Dog: A Guide to Supporting Your Aging Best Friend and Welcoming a New One published by New World Library. We explore what it really takes to support your aging best friend, while welcoming a new fur family member into the pack. From managing energy levels to honoring emotional needs, Helen shares essential tips and heart-centered wisdom for anyone walking this path. You can follow Helen St. Pierre on Facebook at: No Monkey Business Dog Training or go to her website: nomonkeybusinessdogtraining.com  and you can find her book, Old Dog, New Dog: A Guide to Supporting Your Aging Best Friend and Welcoming a New One on Amazon. Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, Google Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast.  Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook.  You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, and her Community Empowerment and Cross-Generational Consultation Services by going to: www.korewomen.com. Thank you for listening! Please share this podcast with your family and friends. #SeniorDogs #DogTrainingTips #PetGriefSupport #DogCarePodcast #AnimalAdvocacy 

Today, we'll be talking about psychedelics and addiction psychiatry, what they are, how they work, and what the research actually tells us. CME: Take the CME Post-Test for this EpisodePublished On: 10/13/2025Duration: 23 minutes, 38 secondsNoah Capurso, MD, MHS, and Snehal Bhatt, MD, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

How do retina specialists first broach the topic of complement inhibition for GA therapy? In episode 1 of this miniseries, moderator Charles Wykoff, MD, PhD, speaks with Maryam Ghiassi, MD, MHS, and Matthew Cunningham, MD, about timing treatment conversations, managing  patients with one good and one bad eye, and addressing whether patients can maintain driving. Editorially independent content, supported by an educational grant from Apellis Pharmaceuticals.

Four to be recognized as lifesavers at Petit Jean State Park; UACCM, Perry County to get TAP Grants; Conway County Fire Department offers Fire Prevention Month tips; Conway County Cleanup winding down; Adelaide Club getting ready for annual Angel Tree effort; MJHS Recognized for improvement on ATLAS test; MHS volleyball wins conference matches; MJHS puts perfect record on the line at Greenbrier; we visit with Sacred Heart Coaches Kyle Duvall and Daniel Johnson.

This week on the KORE Women podcast, Dr. Summer Watson is joined by Wendy Valentine, author of Women Waking Up: The Midlife Manifesto for Passion, Purpose, and Play and host of the top-rated Midlife Makeover Show podcast. Once stuck in fear and overwhelm, Wendy turned her life around and now helps other women do the same. We talk about breaking free from limiting beliefs, embracing reinvention, and why midlife can be the most empowered chapter of your life. Listen in and get inspired to wake up to what's possible. You can connect with Wendy Valentine on Instagram, TikTok, Pinterest at: Wendy_Valentine on Facebook at: Wendy.Kuhn.16 and you can find her book on Amazon.  Instagram:  https://www.instagram.com/wendy_valentine_ TikTok: https://www.tiktok.com/@wendy_valentine_ Facebook:  https://www.facebook.com/wendy.kuhn.16 Pinterest:  https://www.pinterest.com/wendy_valentine_/ Here's the link to the book's product page on Amazon:  https://a.co/d/7NgRXE7. Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, Google Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast.  Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook.  You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, and her Community Empowerment and Cross-Generational Consultation Services by going to: www.korewomen.com. Thank you for listening! Please share this podcast with your family and friends. #KOREWomenPodcast #WomenWakingUp #MidlifeMakeover #MidlifeEmpowerment 

10-3-25 MHS 57-FHS 6 by MBC Grand, Inc.

Heather E. Whitson, MD, MHS explores how resilience—the ability to recover and adapt after stress or illness—changes across the lifespan. She explains that bounce back slows with age and that people age at different rates, influenced by biology, lifestyle, and environment. Studies connect lower inflammation, stronger cellular health, and emotional well-being to better recovery, such as regaining mobility after hip fracture or coping with persistent pain. Whitson also highlights how changes in the brain, like the buildup of amyloid and tau proteins, begin years before memory problems, underscoring the importance of early prevention. She points to practical steps that support resilience at any age: staying active, eating a Mediterranean style diet, managing blood pressure and blood sugar, protecting vision, engaging socially and mentally, prioritizing sleep, avoiding harmful exposures, and preventing injuries. Series: "Stein Institute for Research on Aging" [Health and Medicine] [Show ID: 40959]

Perry Co. burglary from 2023 solves after DNA hit; MHS, PHS celebrate Homecoming; Lots of local festivals & events taking place Saturday; Football Friday preview; We visit with Alicia Hugen with the Conway Co. Extension Service

Heather E. Whitson, MD, MHS explores how resilience—the ability to recover and adapt after stress or illness—changes across the lifespan. She explains that bounce back slows with age and that people age at different rates, influenced by biology, lifestyle, and environment. Studies connect lower inflammation, stronger cellular health, and emotional well-being to better recovery, such as regaining mobility after hip fracture or coping with persistent pain. Whitson also highlights how changes in the brain, like the buildup of amyloid and tau proteins, begin years before memory problems, underscoring the importance of early prevention. She points to practical steps that support resilience at any age: staying active, eating a Mediterranean style diet, managing blood pressure and blood sugar, protecting vision, engaging socially and mentally, prioritizing sleep, avoiding harmful exposures, and preventing injuries. Series: "Stein Institute for Research on Aging" [Health and Medicine] [Show ID: 40959]

Heather E. Whitson, MD, MHS explores how resilience—the ability to recover and adapt after stress or illness—changes across the lifespan. She explains that bounce back slows with age and that people age at different rates, influenced by biology, lifestyle, and environment. Studies connect lower inflammation, stronger cellular health, and emotional well-being to better recovery, such as regaining mobility after hip fracture or coping with persistent pain. Whitson also highlights how changes in the brain, like the buildup of amyloid and tau proteins, begin years before memory problems, underscoring the importance of early prevention. She points to practical steps that support resilience at any age: staying active, eating a Mediterranean style diet, managing blood pressure and blood sugar, protecting vision, engaging socially and mentally, prioritizing sleep, avoiding harmful exposures, and preventing injuries. Series: "Stein Institute for Research on Aging" [Health and Medicine] [Show ID: 40959]

Heather E. Whitson, MD, MHS explores how resilience—the ability to recover and adapt after stress or illness—changes across the lifespan. She explains that bounce back slows with age and that people age at different rates, influenced by biology, lifestyle, and environment. Studies connect lower inflammation, stronger cellular health, and emotional well-being to better recovery, such as regaining mobility after hip fracture or coping with persistent pain. Whitson also highlights how changes in the brain, like the buildup of amyloid and tau proteins, begin years before memory problems, underscoring the importance of early prevention. She points to practical steps that support resilience at any age: staying active, eating a Mediterranean style diet, managing blood pressure and blood sugar, protecting vision, engaging socially and mentally, prioritizing sleep, avoiding harmful exposures, and preventing injuries. Series: "Stein Institute for Research on Aging" [Health and Medicine] [Show ID: 40959]

Heather E. Whitson, MD, MHS explores how resilience—the ability to recover and adapt after stress or illness—changes across the lifespan. She explains that bounce back slows with age and that people age at different rates, influenced by biology, lifestyle, and environment. Studies connect lower inflammation, stronger cellular health, and emotional well-being to better recovery, such as regaining mobility after hip fracture or coping with persistent pain. Whitson also highlights how changes in the brain, like the buildup of amyloid and tau proteins, begin years before memory problems, underscoring the importance of early prevention. She points to practical steps that support resilience at any age: staying active, eating a Mediterranean style diet, managing blood pressure and blood sugar, protecting vision, engaging socially and mentally, prioritizing sleep, avoiding harmful exposures, and preventing injuries. Series: "Stein Institute for Research on Aging" [Health and Medicine] [Show ID: 40959]

Interviewee: Bassel Shanab, BS is a fourth-year medical student at the Yale School of Medicine.  Interviewer:  Lisa Meeks, PhD, MA, Guest Editor, Academic Medicine Supplement on Disability Inclusion in UME. Description: This episode of Stories Behind the Science sits down with Bassel Shanab (Yale School of Medicine), co-first author of “The Intersection of Disability, Race, Ethnicity, and Financial Background on Food Insecurity Among Medical Students,” part of the Academic Medicine supplement on Disability Inclusion in UME. We move beyond prevalence rates to the lived realities behind them—and why hunger so often hides in plain sight in elite training environments. Bassel shares the personal experiences that shaped his questions, the multi-institutional data that sharpened the answers, and the practical moves any school can make now: screen routinely, get cost-of-living estimates right, normalize help-seeking, and invest in evidence-based campus supports. Along the way, we talk flourishing (not just “fixing”), student-led research networks, and why transparency beats stigma every time. Whether you're a dean, DRP, faculty member, or student, this conversation offers a humane roadmap from surviving to thriving. Links to the open-access article, and related tools are in the show notes. Transcript:  https://docs.google.com/document/d/184LJqvcAgHGmpHyOcaxOxRw4yetR7qrGPPin0HDX7i4/edit?usp=sharing   Bios:   Bassel Shanab, BS is a fourth-year medical student at the Yale School of Medicine. He holds a Bachelor of Arts in Biological Sciences and Global Health Studies from Northwestern University, graduating with distinction. His academic interests include medical education, cardiovascular health, social determinants of health, and health policy. Key Words:   Food insecurity Medical students Disability Race and ethnicity Underrepresented in medicine (URiM) Low-income background Intersectionality Student well-being Academic performance   Resources:  Article from Today's Talk The Intersection of Disability, Race, Ethnicity, and Financial Background on Food Insecurity Among Medical Students   Nguyen, Mytien MS; Shanab, Bassel M.; Khosla, Pavan; Boatright, Dowin MD, MBA, MHS; Chaudhry, Sarwat I. MD; Brandt, Eric J. MD, MHS; Hammad, Nour M. MS; Grob, Karri L. EdD, MA; Brinker, Morgan; Cannon, Caden; Cermack, Katherine; Fathali, Maha; Kincaid, John W.R. MS, MPhil; Ma, Yuxing Emily; Ohno, Yuu MS; Pradeep, Aishwarya; Quintero, Anitza MBA; Raja, Neelufar; Rooney, Brendan L.; Stogniy, Sasha; Smith, Kiara K.; Sun, George; Sunkara, Jahnavi; Tang, Belinda; Rubick, Gabriella VanAken MD; Wang, JiCi MD; Bhagwagar, Sanaea Z.; Luzum, Nathan; Liu, Frank MS; Francis, John S. MD, PhD; Meeks, Lisa M. PhD, MA; Leung, Cindy W. PhD. The Intersection of Disability, Race, Ethnicity, and Financial Background on Food Insecurity Among Medical Students. Academic Medicine 100(10S):p S113-S118, October 2025. | DOI: 10.1097/ACM.0000000000006156   https://journals.lww.com/academicmedicine/fulltext/2025/10001/the_intersection_of_disability,_race,_ethnicity,.12.aspx The Docs With Disabilities Podcast https://www.docswithdisabilities.org/docswithpodcast

Conway Co. Fall Cleanup is next week; MHS hosting band competition on Saturday; Volunteers needed to place on veterans' graves at Elmwood Cemetery; Rural Fire Show is Saturday; Several local teams in action; We visit with Jeremy Kissire and Trent Anderson about Shop with a Cop

In this Talk Dizzy to Me episode, vestibular physical therapists Dr. Abbie Ross, PT, NCS and Dr. Dani Tolman, PT sit down with Dr. Mike Studer, DPT, MHS, NCS, CEEAA, CWT, CSST, CSRP, CBFP, FAPTA to unpack neuroplasticity—what it is, how it works, and how to apply it in vestibular rehabilitation. We cover dual tasking, prediction error, fear-avoidant vs. fear-adapted movement, motivational interviewing, and patient-directed dosage using the OPTIMAL theory of motor learning. Mike shares practical clinic and real-life examples (driving, grocery stores, cooking), mic-drop lines you'll quote to patients, and how to talk to insurers using objective measures.If busy visuals or movement bother you, consider listening on Apple Podcasts/Spotify.Neuroplasticity = learning. It's not just more pathways; it's stronger, faster, better-fed pathways that consolidate during sleep.Dose the meaningful. Intensity, repetitions, salience, and task specificity drive consolidation (“put a post-it on that memory”).Exposure works. Habituation/adaptation creates prediction error (“that wasn't as bad as I expected”), reinforcing change via dopamine.Fear shows up in movement. Beyond fear-avoidant behavior, watch for fear-adapted movement (reduced head turns, co-contraction, slow/over-intentional strategies).Dual tasking is two goals, not ‘think-and-move' toward one goal. Use cognitive+motor or visual+motor loads that are personally salient.Autonomy accelerates progress. Let patients choose dosage (keep, dial down, or push), using motivational interviewing and OPTIMAL theory.No expiration date. Neuroplastic change remains possible well beyond 1 year—set expectations and use objective measures to justify care.Connect with MikeEmail: mike@mikestuder.comWebsite: mikestuder.comInstagram: @MikeStuderDPTBook: The Brain That Chooses ItselfTime Stamps03:29 Neuroplasticity defined 05:21 Core principles: intensity, repetitions, salience, task specificity, sleep consolidation09:35 Zooming into vestibular rehab10:06 VR as proof of neuroplasticity; predictive processing 11:32 Habituation/adaptation as exposure-based therapy; links to pain & psychology13:32 Fear, expectations, and patient education14:28 Therapeutic alliance: precision starts with the person17:42 Treating fear: exposure-response prevention & prediction error (dopamine wins)20:05 Dosage variables + motivational interviewing + OPTIMAL theory21:27 Threat perception, amygdala, and “roadblocking” fear pathways24:13 Fear-avoidant vs. fear-adapted movement (new concept in progress)26:11 Cognitive load, exhaustion, and dual-task intolerance29:32 Building alliance between sessions (check-ins)30:00 What dual tasking is (and isn't): two separate goals31:32 Clinic examples: cognitive+motor; visual+motor with busy backgrounds34:51 Real life: driving with kids, grocery stores, cooking; task switching vs. dual tasking38:40 Overtraining in clinic to empower life outside39:10 Progression: patient-controlled dosage (autonomy)43:27 Neuroplasticity at any age; caveats for degenerative conditions45:26 “Road crew at night” metaphor; why sleep matters47:13 The “1-year” myth; talking to insurers with objective measures49:27 Mic-drop linesHosted by:

This week on the KORE Women Podcast, Dr. Summer Watson welcomes visionary author Bibiana Krall to the show! She's the mind behind Deathcap, a modern gothic novel full of mystery, myth, and the macabre and co-creator of the award-winning Haunted Series. During this episode, we explore her creative process, the rise of her YouTube series, House of Mirrors, and how speculative fiction can reflect our deepest truths. This conversation is gothic, gorgeous, and full of insight for creatives everywhere. You can connect with Bibiana Krall on:  LinkedIn and Instagram, on YouTube at: Black Calyx Books, and at: www. BibianaKrall.com WWW.INSTAGRAM.COM/BIBIANAKRALL WWW.YOUTUBE.COM/@BLACKCALYXBOOKS SITE: WWW.BIBIANAKRALL.COM/BIO Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, Google Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast.  Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook.  You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, and her Community Empowerment and Cross-Generational Consultation Services by going to: www.korewomen.com. Thank you for listening! Please share this podcast with your family and friends. #KOREWomenPodcast #BibianaKrall #Deathcap #HauntedSeries #ModernGothic 

About this episode: Does acetaminophen use during pregnancy cause autism in children? In this episode: Brian Lee, who led the largest study on acetaminophen use and neurodevelopmental outcomes, walks through the study's findings—as well as the challenges of researching the causal effects of medication use during pregnancy. Then, biostatistician Elizabeth Stuart discusses how she thinks about assessing potential cause-and-effect relationships when studies have different strengths and weaknesses. Guest: Brian Lee, PhD, MHS, is a professor of epidemiology and biostatistics at the Dornsife School of Public Health at Drexel University.   Elizabeth Stuart, PhD, is Chair in the Department of Biostatistics at the Johns Hopkins Bloomberg School of Public Health, where she focuses on designing and interpreting studies exploring causal effects. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Acetaminophen Use During Pregnancy and Children's Risk of Autism, ADHD, and Intellectual Disability—JAMA What the evidence tells us about Tylenol, leucovorin, and autism—STAT Discovering How Environment Affects Autism—Hopkins Bloomberg Public Health Magazine Does A Really Cause B? How a Biostatistician Thinks About Causality—Public Health On Call (August 2024) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

There are two variations of long-acting injectable buprenorphine on the market. But what differentiates them, who might benefit, and how well do they work? Find out in today's podcast.CME: Take the CME Post-Test for this EpisodePublished On: 09/29/2025Duration: 11 minutes, 36 secondsNoah Capurso, MD, MHS, and Geneva Valeska have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Welcome to Monday Night Talk podcast for September 22, 2025! Guests and topics for this podcast includes the State House Report with State Auditor Diana DiZoglio who will provide an update on her attempt to get lawmakers to comply to a voter approved ballot question last November authorizing an audit of the state legislature. Peter Brown, President of Tiny & Sons Glass talks about attending the Auto Glass Week conference, receiving a very prestigious award, the importance of these conferences and how technology has changed the landscape for glass replacement. Peter Drummey, Chief Historian for the Massachusetts Historical Society is set to retire after 47 years with the institution. He stops by to talk about the various roles he's served in, the knowledge he's gained from the society's collections during his time at the MHS and how he plans to spend his retirement. Casey Sherman, a New York Times bestselling author, stops by to talk about his latest book project and pending true crime docu-series. Monday Night Talk is proudly sponsored by Tiny & Sons Glass, Old Colony Planning Council and Alcoholics Anonymous. Do you have a topic for a future show or info on an upcoming community event? Email us at mondaynighttalk@gmail.com If you're a fan of the show and enjoy our segments, you can either download your favorite segment from this site or subscribe to our podcasts through iTunes & Spotify today!  Monday Night Talk with Kevin Tocci, Copyright © 2025.

Welcome to Monday Night Talk podcast for September 22, 2025! The guest and topics for this segment features Peter Drummey, Chief Historian for the Massachusetts Historical Society, who is set to retire after 47 years with the institution. He stops by to talk about the various roles he's served in, the knowledge he's gained from the society's collections during his time at the MHS and how he plans to spend his retirement.  Monday Night Talk is proudly sponsored by Tiny & Sons Glass, Old Colony Planning Council and Alcoholics Anonymous. Do you have a topic for a future show or info on an upcoming community event? Email us at mondaynighttalk@gmail.com If you're a fan of the show and enjoy our segments, you can either download your favorite segment from this site or subscribe to our podcasts through iTunes & Spotify today!  Monday Night Talk with Kevin Tocci, Copyright © 2025.

A potential functional cure for HIV could be just months away from human trials. Dr. Lanna reveals how her company Sentcell is using cellular rejuvenation to eliminate HIV reservoirs—and the surprising anti-aging benefits that come with it.n this groundbreaking interview, Dr. Lanna, founder and CEO of Sentcell, explains how his team has developed a revolutionary approach to HIV treatment that could eliminate the need for lifelong antiretroviral therapy. Unlike traditional strategies that target the virus directly, Sentcell's method uses a molecule called DOS to rejuvenate CD4 T-cells, triggering them to naturally clear HIV DNA from their own genomes through a process that mimics elite controllers—rare individuals who can suppress HIV without medication. The treatment works by reactivating dormant cellular pathways that outcompete HIV's integration machinery, effectively reversing viral integration and clearing infected cells within days to weeks. Beyond HIV, Dr. Lanna discusses his team's discovery of "rivers of telomeres"—vesicle structures released by rejuvenated T-cells that can systemically rejuvenate other organs and extend lifespan by 12-17 months in animal studies. With Phase 1 human trials planned for 2026 at University College London, this research represents a potential paradigm shift from managing HIV as a chronic condition to achieving a functional cure.

9-26-25 MHS 49-FM 8 by MBC Grand, Inc.

Paroxysmal movement disorders refer to a group of highly heterogeneous disorders that present with attacks of involuntary movements without loss of consciousness. These disorders demonstrate considerable and ever-expanding genetic and clinical heterogeneity, so an accurate clinical diagnosis has key therapeutic implications. In this episode, Kait Nevel, MD, speaks with Abhimanyu Mahajan, MD, MHS, FAAN, author of the article “Paroxysmal Movement Disorders” in the Continuum® August 2025 Movement Disorders issue. Dr. Nevel is a Continuum® Audio interviewer and a neurologist and neuro-oncologist at Indiana University School of Medicine in Indianapolis, Indiana. Dr. Mahajan is an assistant professor of neurology and rehabilitation medicine at the James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders at the University of Cincinnati in Cincinnati, Ohio. Additional Resources Read the article: Paroxysmal Movement Disorders Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @IUneurodocmom Guest: @MahajanMD Full episode transcript available here Dr Jones: This is Doctor Lyell Jones, editor in chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Nevel: Hello, this is Dr Kait Nevel. Today I'm interviewing doctor Abhi Mahajan about his article on diagnosis and management of paroxysmal movement disorders, which appears in the August 2025 Continuum issue on movement disorders. Abhi, welcome to the podcast and please introduce yourself to the audience. Dr Mahajan: Thank you, Kait. Thank you for inviting me. My name is Abhi Mahajan. I'm an assistant professor of neurology and rehabilitation medicine at the University of Cincinnati in Cincinnati, Ohio. I'm happy to be here. Dr Nevel: Wonderful. Well, I'm really excited to talk to you about your article today on this very interesting and unique set of movement disorders. So, before we get into your article a little bit more, I think just kind of the set the stage for the discussion so that we're all on the same page. Could you start us off with some definitions? What are paroxysmal movement disorders? And generally, how do we start to kind of categorize these in our minds? Dr Mahajan: So, the term paroxysmal movement disorders refers to a group of highly heterogeneous disorders. These may present with attacks of involuntary movements, commonly a combination of dystonia and chorea, or ataxia, or both. These movements are typically without loss of consciousness and may follow, may follow, so with or without known triggers. In terms of the classification, these have been classified in a number of ways. Classically, these have been classified based on the trigger. So, if the paroxysmal movement disorder follows activity, these are called kinesigenic, paroxysmal, kinesigenic dyskinesia. If they are not followed by activity, they're called non kinesigenic dyskinesia and then if they've followed prolonged activity or exercise they're called paroxysmal exercise induced dyskinesia. There's a separate but related group of protogynous movement disorders called episodic attacks here that can have their own triggers. Initially this was the classification that was said. Subsequent classifications have placed their focus on the ideology of these attacks that could be familiar or acquired and of course understanding of familiar or genetic causes of paroxysmal movement disorders keeps on expanding and so on and so forth. And more recently, response to pharmacotherapy and specific clinical features have also been introduced into the classification. Dr Nevel: Great, thank you for that. Can you share with us what you think is the most important takeaway from your article for the practicing neurologist? Dr Mahajan: Absolutely. I think it's important to recognize that everything that looks and sounds bizarre should not be dismissed as malingering. Such hyperkinetic and again in quotations, “bizarre movements”. They may appear functional to the untrained eye or the lazy eye. These movements can be diagnosed. Paroxysmal movement disorders can be diagnosed with a good clinical history and exam and may be treated with a lot of success with medications that are readily available and cheap. So, you can actually make a huge amount of difference to your patients' lives by practicing old-school neurology. Dr Nevel: That's great, thank you so much for that. I can imagine that scenario does come up where somebody is thought to have a functional neurological disorder but really has a proximal movement disorder. You mentioned that in your article, how it's important to distinguish between these two, how there can be similarities at times. Do you mind giving us a little bit more in terms of how do we differentiate between functional neurologic disorder and paroxysmal movement disorder? Dr Mahajan: So clinical differentiation of functional neurological disorder from paroxysmal movement disorders, of course it's really important as a management is completely different, but it can be quite challenging. There's certainly an overlap. So, there can be an overlap with presentation, with phenomenology. Paroxysmal nature is common to both of them. In addition, FND and PMD's may commonly share triggers, whether they are movement, physical exercise. Other triggers include emotional stimuli, even touch or auditory stimuli. What makes it even more challenging is that FND's may coexist with other neurological disorders, including paroxysmal movement disorders. However, there are certain specific phenom phenotypic differences that have been reported. So specific presentations, for example the paroxysms may look different. Each paroxysm may look different in functional neurological disorders, specific phenotypes like paroxysmal akinesia. So, these are long duration episodes with eyes closed. Certain kinds of paroxysmal hyperkinesia with ataxia and dystonia have been reported. Of course. More commonly we see PNES of paroxysmal nonepileptic spells or seizures that may be considered paroxysmal movement disorders but represent completely different etiology which is FND. Within the world of movement disorders, functional jerks may resemble propiospinal myoclonus which is a completely different entity. Overall, there are certain things that help separate functional movement disorders from paroxysmal movement disorders, such as an acute onset variable and inconsistent phenomenology. They can be suggestibility, distractibility, entrainment, the use of an EMG may show a B-potential (Bereitschaftspotential) preceding the movement in patients with FND. So, all of these cues are really helpful. Dr Nevel: Great, thanks. When you're seeing a patient who's reporting to these paroxysmal uncontrollable movements, what kind of features of their story really tips you off that this might be a proximal movement disorder? Dr Mahajan: Often these patients have been diagnosed with functional neurological disorders and they come to us. But for me, whenever the patient and or the family talk about episodic movements, I think about these. Honestly, we must be aware that there is a possibility that the movements that the patients are reporting that you may not see in clinic. Maybe there are obvious movement disorders. Specifically, there's certain clues that you should always ask for in the history, for example, ask for the age of onset, a description of movements. Patients typically have videos or families have videos. You may not be able to see them in clinic. The regularity of frequency of these movements, how long the attacks are, is there any family history of or not? On the basis of triggers, whether, as I mentioned before, do these follow exercise? Prolonged exercise? Or neither of the above? What is the presentation in between attacks, which I think is a very important clinical clue. Your examination may be limited to videos, but it's important not just to examine the video which represents the patient during an attack, but in between attacks. That is important. And of course, I suspect we'll get to the treatment, but the treatment can follow just this part, the history and physical exam. It may be refined with further testing, including genetic testing. Dr Nevel: Great. On the note of genetic testing, when you do suspect a diagnosis of paroxysmal movement disorder, what are some key points for the provider to be aware of about genetic testing? How do we go about that? I know that there are lots of different options for genetic testing and it gets complicated. What do you suggest? Dr Mahajan: Traditionally, things were a little bit easier, right, because we had a couple of genes that have been associated with the robust movement disorders. So, genetic testing included single gene testing, testing for PRRT2 followed by SLC2A. And if these were negative, you said, well, this is not a genetic ideology for paroxysmal movement disorders. Of course, with time that has changed. There's an increase in known genes and variants. There is increased genetic entropy. So, the same genetic mutation may present with many phenotypes and different genetic mutations may present with the similar phenotype. Single gene testing is not a high yield approach. Overall genetic investigations for paroxysmal movement disorders use next generation sequencing or whole exome sequence panels which allow for sequencing of multiple genes simultaneously. The reported diagnostic yield with let's say next generation sequencing is around 35 to 50 percent. Specific labs at centers have developed their own panels which may improve the yield of course. In children, microarray may be considered, especially the presentation includes epilepsy or intellectual disability because copy number variations may not be detected by a whole exome sequencing or next generation sequencing. Overall, I will tell you that I'm certainly not an expert in genetics, so whenever you're considering genetic testing, if possible, please utilize the expertise of a genetic counsellor. Families want to know, especially as an understanding of the molecular underpinnings and knowledge about associated mutations or variations keeps on expanding. We need to incorporate their expertise. A variant of unknown significance, which is quite a common result with genetic testing, may not be a variant of unknown significance next year may be reclassified as pathogenic. So, this is extremely important. Dr Nevel: Yeah. That's such a good point. Thank you. And you just mentioned that there are some genetic mutations that can lead to multiple different phenotypes. Seemingly similar phenotypes can be associated with various genetic mutations. What's our understanding of that? Do we have an understanding of that? Why there is this seeming disconnect at times between the specific genetic mutation and the phenotype? Dr Mahajan: That is a tough question to answer for all paroxysmal movement disorders because the answer may be specific to a specific mutation. I think a great example is the CACNA1A mutation. It is a common cause of episodic ataxia type 2. Depending on when the patient presents, you can have a whole gamut of clinical presentations. So, if the patient is 1 year old, the patient can present with epileptic encephalopathy. Two to 5 years, it can be benign paroxysmal torticollis of infancy. Five to 10 years, can present with learning difficulties with absence epilepsy and then of course later, greater than 10 years, with episodic ataxia (type) 2 hemiplegic migraine and then a presentation with progressive ataxia and hemiplegic migraines has also been reported. So not just episodic progressive form of ataxia has also been reported. I think overall these disorders are very rare. They are even more infrequently diagnosed than their prevalence. As such, the point that different genetic mutations present with different phenotypes, or the same genetic mutation I may present with different phenotypes could also represent this part. Understanding of the clinical presentation is really incomplete and forever growing. There's a new case report or case series every other month, which makes this a little bit challenging, but that's all the more reason for learning about them and for constant vigilance for patients who show up to our clinic. Dr Nevel: Yeah, absolutely. What is our current understanding of the associated pathophysiology of these conditions and the pathophysiology relating to the genetics? And then how does that relate to the treatment of these conditions? Dr Mahajan: So, a number of different disease mechanisms have been proposed. Traditionally, these were all thought to be ion channelopathies, but a number of different processes have been proposed now. So, depending on the genetic mutation that you talk about. So certain mutations can involve ion channels such as CACMA1A, ATP1A3. It can involve solute carriers, synaptic vesicle fusion, energy metabolism such as ECHS1, synthesis of neurotransmitters such as GCH1. So, there are multiple processes that may be involved. I think overall for the practicing clinician such as me, I think there is a greater need for us to understand the underlying genetics and associated phenotypes and the molecular mechanisms specifically because these can actually influence treatment decisions, right? So, you mentioned that specific genetic testing understanding of the underlying molecular mechanism can influence specific treatments. As an example, a patient presenting with proximal nocturnal dyskinesia with mutation in the ADCY5 gene may respond beautifully to caffeine. Other examples if you have SLC2A1, so gluc-1 (glucose transporter type 1) mutation, a ketogenic diet may work really well. If you have PDHA1 mutation that may respond to thiamine and so on and so forth. There are certain patients where paroxysmal movement disorders are highly disabling and you may consider deep brain stimulation. That's another reason why it may be important to understand genetic mutations because there is literature on response to DBS with certain mutations versus others. Helps like counselling for patients and families, and of course introduces time, effort, and money spent in additional testing. Dr Nevel: Other than genetic testing, what other diagnostic work up do you consider when you're evaluating patients with a suspected paroxysmal movement disorder? Are there specific things in the history or on exam that would prompt you to do certain testing to look for perhaps other things in your differential when you're first evaluating a patient? Dr Mahajan: In this article, I provide a flow chart that helps me assess these patients as well. I think overall the history taking and neurological exam outside of these paroxysms is really important. So, the clinical exam in between these episodic events, for example, for history, specific examples include, well, when do these paroxysms happen? Do they happen or are they precipitated with meals that might indicate that there's something to do with glucose metabolism? Do they follow exercise? So, a specific example is in Moyamoya disease, they can be limb shaking that follows exercise. So, which gives you a clue to what the etiology could be. Of course, family history is important, but again, talking about the exam in between episodes, you know, this is actually a great point because out– we've talked about genetics, we've talked about idiopathic paroxysmal movement disorders, –but a number of these disorders are because of acquired causes. Well, of course it's important because acquired causes such as autoimmune causes, so multiple sclerosis, ADEM, lupus, LGI1, all of these NMDAR, I mentioned Moyamoya disease and metabolic causes. Of course, you can consider FND as under-acquired as well. But all of these causes have very different treatments and they have very different prognosis. So, I think it's extremely important for us to look into the history with a fine comb and then examine these patients in between these episodes and keep our mind open about acquired causes as well. Dr Nevel: When you evaluate these patients, are you routinely ordering vascular imaging and autoimmune kind of serologies and things like that to evaluate for these other acquired causes or it does it really just depend on the clinical presentation of the patient? Dr Mahajan: It mostly depends on the clinical presentation. I mean, if the exam is let's say completely normal, there are no other risk factors in a thirty year old, then you know, with a normal exam, normal history, no other risk factors. I may not order an MRI of the brain. But if the patient is 55 or 60 (years) with vascular risk factors, then you have to be mindful that this could be a TIA. If the patient has let's say in the 30s and in between these episodes too has basically has a sequel of these paroxysms, then you may want to consider autoimmune. I think the understanding of paraneoplastic, even autoimmune disorders, is expanding as well. So, you know the pattern matters. So, if all of this is subacute started a few months ago, then I have a low threshold for ordering testing for autoimmune and paraneoplastic ideology is simply because it makes such a huge difference in terms of how you approach the treatment and the long-term prognosis. Dr Nevel: Yeah, absolutely. What do you find most challenging about the management of patients with paroxysmal movement disorders? And then also what is most rewarding? Dr Mahajan: I think the answer to both those questions is, is the same. The first thing is there's so much advancement in what we know and how we understand these disorders so regularly that it's really hard to keep on track. Even for this article, it took me a few months to write this article, and between the time and I started and when I ended, there were new papers to include new case reports, case series, right? So, these are rare disorders. So most of our understanding for these disorders comes from case reports and case series, and it's in a constant state of advancement. I think that is the most challenging part, but it's also the most interesting part as well. I think the challenging and interesting part is the heterogeneity of presentation as well. These can involve just one part of your body, your entire body can present with paroxysmal events, with multiple different phenomenologies and they might change over time. So overall, it's highly rewarding to diagnose such patients in clinic. As I said before, you can make a sizeable difference with the medication which is usually inexpensive, which is obviously a great point to mention these days in our health system. But with anti-seizure drugs, you can put the right diagnosis, you can make a huge difference. I just wanted to make a point that this is not minimizing in any way the validity or the importance of diagnosing patients with functional neurological disorders correctly. Both of them are as organic. The importance is the treatment is completely different. So, if you're diagnosing somebody with FND and they do have FND and they get cognitive behavioral therapy and they get better, that's fantastic. But if somebody has paroxysmal movement disorders and they undergo cognitive behavioral therapy and they're not doing well, that doesn't help anybody. Dr Nevel: One hundred percent. As providers, obviously we all want to help our patients and having the correct diagnosis, you know, is the first step. What is most interesting to you about paroxysmal movement disorders? Dr Mahajan: So outside of the above, there are some unanswered questions that I find very interesting. Specifically, the overlap with epilepsy is very interesting, including shared genes, the episodic nature, presence of triggers, therapeutic response to anti-seizure drugs. All of this I think deserves further study. In the clinic, you may find that epilepsy and prognosis for movement disorders may occur in the same individual or in a family. Episodic ataxia has been associated with seizures. Traditionally this dichotomy of an ictal focus. If it's cortical then it's epilepsy, if it's subcortical then it's prognosis for movement disorders. This is thought to be overly simplistic. There can be co-occurrence of seizures and paroxysmal movement disorders in the same patient and that has led to this continuum between these two that has been proposed. This is something that needs to be looked into in more detail. Our colleagues in Epilepsy may scoff this, but there's concept of basal ganglia epilepsy manifesting as paroxysmal movement disorders was proposed in the past. And there was this case report that was published out of Italy where there was ictal discharge from the supplementary sensory motor cortex with a concomitant discharge from the ipsilateral coordinate nucleus in a patient with paroxysmal kinesigenic cardioarthidosis. So again, you know, basal ganglia epilepsy, no matter what you call it, the idea is that there is a clear overlap between these two conditions. And I think that is fascinating. Dr Nevel: Really interesting stuff. Well, thank you so much for chatting with me today. Dr Mahajan: Thank you, Kait. And thank you to the Continuum for inviting me to write this article and for this chance to speak about it. I'm excited about how it turned out, and I hope readers enjoy it as well. Dr Nevel: Today again, I've been interviewing doctor Abhi Mahajan about his article on diagnosis and management of paroxysmal movement disorders, which appears in the August 2025 Continuum issue on movement disorders. I encourage all of our listeners to be sure to check out the Continuum Audio episodes from this and other issues. As always, please read the Continuum articles where you can find a lot more information than what we were able to cover in our discussion today. And thank you for our listeners for joining today. And thank you, Abhi, so much for sharing your knowledge with us today. Dr Monteith: This is Dr Teshamae Monteith, associate editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

9-23-25 PHS 3-MHS 2 by MBC Grand, Inc.

This week on the KORE Women podcast, Dr. Summer Watson is joined by Debbie Prediger, who is a visionary strategist and founder of the Be Extraordinary Women's Network and Empowering YOU Community. We explore how women can step into aligned visibility, amplify their message, and lead not in isolation, but in powerful ways together. Debbie shares her journey, her frameworks, and her fire to help women rise into legacy and leadership You can connect with Debbie at: https://askdebbie.club Empowering You Community with Debbie Prediger on Facebook: https://www.facebook.com/groups/empoweringyoufreegroup And on LinkedIn at: Debbie Prediger Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, Google Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast.  Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook.  You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, and her Community Empowerment and Cross-Generational Consultation Services by going to: www.korewomen.com. Thank you for listening! Please share this podcast with your family and friends. #KOREWomenPodcast #WomenWhoLead #VisibilityWithPurpose #EmpoweringYOU #MentorTheMentors #WomenInCommunity

When someone's LDL cholesterol hits 574 mg/dL, doctors typically expect the worst. But what if everything we think we know about cholesterol and heart disease risk is incomplete?In this episode, I sit down with researchers Nick Norwitz, Adrian Soto-Mota, and Dave Feldman to discuss their groundbreaking study on lean mass hyperresponders - a rare population who develop extremely high LDL cholesterol on ketogenic diets despite being lean, fit, and metabolically healthy. Their recent paper "Plaque Begets Plaque, ApoB Does Not" challenges conventional wisdom by showing that in this unique population, neither LDL cholesterol nor ApoB levels predicted plaque progression over one year of follow-up. Instead, existing plaque was the strongest predictor of future plaque growth. We explore the proposed lipid energy model that may explain why some people's cholesterol skyrockets on keto, discuss the limitations and implications of their findings, and examine what this means for personalized cardiovascular risk assessment. This conversation touches on fundamental questions about causality in medicine, the importance of studying outlier populations, and why a one-size-fits-all approach to cholesterol management may be missing crucial nuances.

Join Dr. Lucinda Cohn as she unpacks the complex world of acne. From what causes those pesky blemishes to the most effective treatments —both over-the-counter and prescription—this episode provides valuable insights for anyone struggling with acne, regardless of age.  Learn more about Lucinda Kohn, MD, MHS 

9-18-25 MHS 41-CHS 0 by MBC Grand, Inc.

This week on the KORE Women Podcast, Dr. Summer Watson welcomes Chloe Street, Chief Connection Officer of Human to Human (HTH), to explore how authentic connection can transform your personal and professional life. We talk about the real “game changers” that create lasting impact, such as tools, mindsets, and skills that help you show up more fully and lead more meaningfully. Chloe shares how human connection is not just a feel-good buzzword but a strategic advantage in today's disconnected world. If you're craving more purpose, alignment, and real momentum in your life and career, this conversation will challenge and inspire you. Tune in for an episode that redefines what it means to grow, lead, and thrive. You can connect with Chloe on:  LinkedIn, on Instagram at Human to Human, on Apple Podcast at: Flow by Chlo, and at: https://www.humantohumanlife.com/ https://www.instagram.com/_humantohuman/ https://podcasts.apple.com/us/podcast/flowbychlo/id1743455549 https://www.humantohumanlife.com/ Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, Google Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast.  Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook.  You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, and her Community Empowerment and Cross-Generational Consultation Services by going to: www.korewomen.com. Thank you for listening! Please share this podcast with your family and friends. #KOREWomenPodcast #LeadershipTips #AuthenticLeadership #PersonalGrowth #CareerCoaching #WomenInLeadership 

Senescent cells were supposed to be the "easy" target in aging research—clear them out and extend healthspan. But new research reveals the field is far more complex than anyone imagined, with major clinical trial setbacks forcing scientists to completely rethink their approach.Some links are affiliate links so we will earn a commission when they are used to purchase products.In this conversation with Dr. Paul Robbins from the University of Minnesota, we explore the evolving world of senescent cell research and senolytics—drugs designed to clear "zombie" cells from our bodies. Dr. Robbins reveals how recent research shows senescence is far more complex than expected, with different types arising from different stresses. We discuss why Unity Biotech's trials failed, mixed results from fisetin studies, and surprising positive signals from Mayo Clinic trials in patients with high senescent cell burden. He explains why future treatments will require personalized cocktails of different senolytics, the potential of alternative approaches, and why he remains optimistic despite setbacks. Dr. Robbins also shares insights into next-generation compounds his lab is developing and hints at positive clinical trial results coming soon.

Do you dream of being a bestselling author? Have you written a book but have no idea how to sell it? Can you envision your message in the hands of thousands of readers? Unlock the secrets to epic book sales with Susan Neal's book How to Sell 1,000 Books a Month. Whether you're a new writer or an experienced author looking to elevate your marketing tactics, this book offers a treasure of insights to significantly boost your sales and increase the effective outreach of your unique message. Susan Neal, an award-winning author and seasoned marketer, condenses years of successful sales and marketing strategies into practical steps that can turn your book into an award-winning bestseller. Learn how to: Create a focused and polished manuscript Captivate and grow your audience Master the art of online marketing Leverage social media to build a compelling author brand Use keywords to boost your book's visibility Harness the power of reviews, blogs, and podcasts to increase sales This guide doesn't just tell you what to do—it shows you how to do it, with detailed action plans tailored for both new and veteran authors. From building a robust marketing plan to planning a book launch to navigating the complexities of Amazon ads, Susan covers everything you need to know to reach—and surpass—your book sales goals. Get a copy of Susan's new book “How to Sell 1000 Books a Month” here: https://amzn.to/46pG6qy   Author Bio As a certified writer coach, Susan Neal, RN, MBA, MHS, desires to help others professionally publish and effectively market their divine-inspired message. She is the author of nine healthy living books. Susan is the CEO of Christian Indie Publishing Association (CIPA), Christian Authors Network (CAN), Christian Indie Awards, and CAN Marketing Awards. She is also the Director of the Blue Lake Christian Writers Conference. You can find Susan at SusanUNeal.com.

This week on the KORE Women podcast, Dr. Summer Watson welcomes Porschia Parker-Griffin, Founder and CEO of Fly High Coaching and host of the Career 101 Podcast. Porschia brings a powerhouse blend of coaching expertise, organizational psychology, and strategic business insight to help companies attract, engage, and retain top talent. With certifications in Myers-Briggs, Hogan Assessment, and Energy Leadership, and a background in financial consulting and leadership development, she's been recognized as a LinkedIn Top Voice and Career Expert. In this conversation, Porschia shares how she helps professionals unlock their full potential and how organizations can build cultures where people thrive. We dive into leadership, career pivots, and the power of self-awareness in professional growth. If you want to engage your workforce, retain top performers, and inspire better leadership– this episode is for you. You can follow Porschia Parker-Griffin on LinkedIn, on Facebook and YouTube at: FlyHighCoaching and at: fly-highcoaching.com.  Website: https://www.fly-highcoaching.com/ LinkedIn: https://www.linkedin.com/in/porschiaparker/ FHC LinkedIn: https://www.linkedin.com/company/64512733/ Facebook: https://www.facebook.com/FlyHighCoaching YouTube Channel: https://www.youtube.com/@flyhighcoaching382 Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, Google Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast.  Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook.  You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, and her Community Empowerment and Cross-Generational Consultation Services by going to: www.korewomen.com. Thank you for listening! Please share this podcast with your family and friends. #KOREWomenPodcast #WomenInLeadership #LeadershipDevelopment #EmployeeEngagement #WorkplaceCulture #RetentionStrategies

In this high-yield episode of Curbsiders Addiction Medicine, we dive deep into a practical and compassionate approach to caring for patients using methamphetamines and/or living with methamphetamine use disorder. We explore the latest pharmacologic options, harm reduction strategies, contingency management, and innovative ideas for monitoring and supporting patients. Whether you're in primary care or other subspecialty settings, this episode is packed with pearls for every clinician with our amazing guest, Dr. Phillip Coffin, Director of the Center on Substance Use and Health in the SFDPH.  Claim CME for this episode at curbsiders.vcuhealth.org! By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education. Episodes | Subscribe | Spotify | iTunes | CurbsidersAddictionMed@gmail.com | CME! Credits Producer/Script Writer/Show Notes: Era Kryzhanovskaya, MD Infographic and Cover Art: Zoya Surani Hosts: Carolyn Chan, MD. MHS and Era Kryzhanovskaya, MD Reviewer: Sarah Leyde MD Showrunner: Carolyn Chan, MD, MHS Technical Production: PodPaste Guest: Dr. Phillip Coffin Show Segments Intro, disclaimer, guest bio Guest one-liner Case from Kashlak; Definitions Four-tier approach to taking care of patients with methamphetamine use/use disorder Medications for treatment Psychosocial treatment Harm reduction New horizons in treatment  Outro Sponsor: Locumstory Learn about locums and get insights from real-life physicians, PAs and NPs at Locumstory.com Sponsor: Panacea Visit panaceafinancial.com and Panacea's Resource Library for free student loan articles, guides, and webinars built to help you make informed decisions. Sponsor: Grammarly  Download Grammarly for free at Grammarly.com/PODCAST

About this episode: The FDA and CDC are tightening eligibility requirements for COVID-19 vaccines this year, pushing effective treatments out of reach for millions of Americans including young children. In this episode: Dr. Fiona Havers, formerly a senior adviser on vaccine policy at the CDC, draws on recent hospitalization rates to identify who is most at risk for severe COVID-19 infection and in need of immunization for protection. Guest: Dr. Fiona Havers, MHS, is an infectious disease physician, a medical epidemiologist, and an expert on vaccine-preventable respiratory diseases and vaccine policy. She previously led the Respiratory Virus Hospitalization Surveillance Network Team at the CDC's National Center for Immunization and Respiratory Diseases. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Recent FDA, CDC changes to COVID vaccination guidelines lead to confusion—WBAL Covid-19 vaccine license change: 12 key questions answered—Your Local Epidemiologist Despite federal shift, state health officials encourage COVID vaccines for pregnant women—Stateline Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

DESCRIPTIONNeuroscience professor Dr. Glen Jeffery from UCL reveals how LED lighting's blue light spike damages mitochondria, accelerates aging, and contributes to diabetes - while explaining simple solutions using red light therapy and incandescent bulbs to protect your health.Neuroscience professor Dr. Glen Jeffery from UCL reveals how LED lighting's blue light spike damages mitochondria, accelerates aging, and contributes to diabetes - while explaining simple solutions using red light therapy and incandescent bulbs to protect your health.

9-4-25 MHS 37-PHS 20 by MBC Grand, Inc.

In this episode of the NCS Podcast Perspectives series, Nicholas Morris, MD, is joined by Chere Chase-Gregory, MD, MHS, senior vice president and chief health equity officer at Novant Health and a practicing neurointensivist. Dr. Chase-Gregory, also an adjunct faculty member at the University of North Carolina and founding member of the Women in Neurocritical Care Committee, shares her path into leadership, the origins of the committee and her ongoing work to advance health equity, mentorship and community partnerships. The views expressed on the NCS Podcast are solely those of the hosts and guests and do not necessarily reflect the opinions or official positions of the Neurocritical Care Society.

This week on The KORE Women podcast, Dr. Summer Watson, PhD welcomes Jessica Lyonford, who is a leadership coach, workplace consultant, and author of The Happy Leader Playbook. We dive into her Eight Pillars of Happiness framework, what it means to lead with joy and purpose, and how high-achieving women can shift from burnout to aligned success. This conversation will challenge the way you think about happiness, leadership, and what truly matters. You can follow Jessica Lyonford on Instagram and LinkedIn and at www.jessicalyonford.com; Check out her podcast, The Project: More Happy Podcast, and you can check out her book, The Happy Leader Playbook on Amazon.  Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, Google Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast.  Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook. You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, and her Community Empowerment and Cross-Generational Consultation Services by going to: www.korewomen.com. Thank you for listening! Please share this podcast with your family and friends. #KOREWomenPodcast #ProjectMoreHappy #PurposeDrivenLeadership #BurnoutRecovery 

Discover why muscle power—not just strength—is the key predictor of healthy aging and longevity. Exercise physiologist Dr. Stuart Phillips reveals groundbreaking research showing that older adults can safely engage in power training, challenging decades of conventional wisdom about senior fitness.In this interview renowned exercise physiologist and gerontology expert Dr. Stuart Phillips from McMaster University shares cutting-edge insights into optimizing exercise and nutrition for healthy aging. Dr. Phillips, who has spent decades researching muscle physiology and aging, breaks down the science behind successful aging and reveals why most people are focusing on the wrong metrics.

This week on The KORE Women podcast, Dr. Summer welcomes Harriet Cabelly, who is a grief therapist who's helped countless people rebuild after loss, until she was faced with her own: a diagnosis of non-Hodgkin's lymphoma. In this powerful episode, Harriet shares how she navigated her cancer journey with the very tools she taught and also discovered unexpected miracles along the way. This is a conversation about courage, vulnerability, and hope in the hardest moments. You can follow Harriett Cabelly on LinkedIn and on Instagram at: Rebuild Life Now Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, Google Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast.  Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook.  You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, and her Community Empowerment and Cross-Generational Consultation Services by going to: www.korewomen.com. Thank you for listening! Please share this podcast with your family and friends. #KOREWomenPodcast #CancerJourney #GriefTherapist #EmotionalHealing 

What if we could train patients for surgery the way elite athletes train for game day? In this episode, we review the science, shed light on the disparities, explore real-world challenges, and honor the behind-the-scenes workers that facilitate prehabilitation in thoracic cancer care. Join attending surgeon Doctor Jinny Ha, 3rd year general surgery resident Doctor Kyla Rakoczy, and Community Outreach Patient Navigator, Leslie Ricks Chandler, in discussing prehabilitation in thoracic surgery. Hosts:  Dr. Jinny Ha, MD, MHS, assistant professor of surgery and thoracic surgeon at Johns Hopkins Leslie Ricks Chandler, Community Outreach Program Advisor Johns Hopkins Thoracic Surgery Dr. Kyla Rakoczy, MD, 3rd year general surgery resident at Johns Hopkins LinkedIn: Kyla Rakoczy Learning objectives:  After listening to this episode, participants will be able to: Define the role and components of prehabilitation in the context of thoracic oncology and ERAS/ESTS guidelines. Interpret key findings from recent clinical trials on prehabilitation, including outcomes related to functional capacity and readmission rates. Identify socioeconomic and structural barriers to prehabilitation participation and discuss strategies to improve equitable access to these interventions. Apply evidence-based criteria to assess which patients may benefit most from preoperative nutrition and exercise interventions. Recognize the importance of interdisciplinary collaboration—including social work and patient navigation—in optimizing surgical readiness and long-term outcomes. References:  Effect of Exercise and Nutrition Prehabilitation on Functional Capacity in Esophagogastric Cancer Surgery: A Randomized Clinical Trial - PubMed https://pmc.ncbi.nlm.nih.gov/articles/PMC12070588/ https://pubmed.ncbi.nlm.nih.gov/39775660/ https://ccts.amegroups.org/article/view/68030/html https://pubmed.ncbi.nlm.nih.gov/36435646/ https://www.sciencedirect.com/science/article/abs/pii/S1043067918301643?via%3Dihub https://pubmed.ncbi.nlm.nih.gov/30304509/ https://pubmed.ncbi.nlm.nih.gov/28385477/ https://pubmed.ncbi.nlm.nih.gov/27226400/ https://pubmed.ncbi.nlm.nih.gov/38546649/  https://pubmed.ncbi.nlm.nih.gov/38614212/ https://www.hopkinsmedicine.org/surgery/specialty-areas/thoracic-surgery/patient-education  Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

This week on the KORE Women Podcast, Dr. Summer Watson welcomes Ahuva Gruen, who was a budding entrepreneur as a kid selling candy to becoming a powerhouse entrepreneur. Ahuva's journey is the ultimate story of resilience and reinvention. She shares how she left corporate life during COVID, rebuilt after divorce, and built her own business, where she empowers entrepreneurs to build sustainable success. Whether you're navigating business growth or personal transformation, Ahuva's wisdom will show you what's possible when you take ownership of your story.  You can follow Ahuva Gruen on LinkedIn and at: www.agfinancialcpa.com Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, Google Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast.  Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook.  You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, and her Community Empowerment and Cross-Generational Consultation Services by going to: www.korewomen.com. Thank you for listening! Please share this podcast with your family and friends. #FinancialFreedom #WomenInFinance #ResilientLeadership #BusinessTransformation #MoneyMindset

JAMA Internal Medicine fellows Jerard Z. Kneifati-Hayek, MD, MS, Ilana B. Richman, MD, MHS, and Nathan Stall, MD, PhD, discuss their experiences learning how to work as members of the editorial team at a leading, widely read, high-impact internal medicine journal. They explore key elements including how the fellowship enhanced their teamwork, writing, critical appraisal, and research skills. Hosted by Ilana B. Richman, MD, MHS. Related Content: Introducing the Expanded JAMA Internal Medicine Editorial Fellowship

This week on the KORE Women Podcast, Dr. Summer Watson welcomes Deborah Kevin founder of Highlander Press, host of STORYTELLHER, and unapologetic disruptor of the status quo. Deborah is on a mission to help women and changemakers tell their stories with boldness, heart, and purpose. In this episode, we talk publishing with soul, writing with courage, and how a trek across Spain shaped her mission to elevate voices that matter. If you're sitting on a story the world needs to hear, this conversation is your sign.  You can follow Deborah Kevin on LinkedIn and at: Highlander Press on: Facebook, Instagram, YouTube, and at: https://highlanderpressbooks.com/.  Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, Google Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast.  Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook.  You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, and her Community Empowerment and Cross-Generational Consultation Services by going to: www.korewomen.com. Thank you for listening! Please share this podcast with your family and friends. #WomenWhoWrite #HighlanderPress #BoldStorytelling #ChangemakerVoices #DisruptTheNorm 

About this episode: Trying to save money on antibiotics, GLP-1 antagonists, or other medications using online pharmacies can pose serious health risks. These sites are flush with substandard and falsified drugs, which can cause adverse side effects, leave serious conditions untreated, and, in some instances, lead to death. In this episode: Dr. Henry Michtalik shares how providers and patients can spot unregulated suppliers and report counterfeit drugs. Guest: Dr. Henry Michtalik, MHS, MPH, is a hospitalist at the Johns Hopkins University School of Medicine and an assistant professor at both the School of Medicine and the Bloomberg School of Public Health. He is a co-principal investigator with the School of Public Health's BESAFE initiative. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: Fake medication is a problem across the world—DW Fake Drugs, Real Danger—Hopkins Bloomberg Public Health Magazine Verify Before You Buy—National Association of Boards of Pharmacy Report a Counterfeit Drug—U.S. Food and Drug Administration Transcript Information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: Since the 1980s, petrochemical production along an 85-mile stretch of the Mississippi River has designated the corridor as “Cancer Alley,” but recent research shows that the risks from air pollution in the region have been seriously underestimated. In this episode: Pete DeCarlo and Keeve Nachman of the Johns Hopkins University discuss their concerning findings about compounding chemical exposure on human health and explain what these conclusions mean for how the United States should regulate carcinogens. Guest: Pete DeCarlo, PhD, is an associate professor in Environmental Health and Engineering at the Johns Hopkins Whiting School of Engineering. Keeve Nachman, PhD, MHS, is the Robert S. Lawrence Professor in Environmental Health and Engineering at the Johns Hopkins Bloomberg School of Public Health. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs. Show links and related content: Air testing reveals cancer-causing gas levels far exceeding some government estimates—ABC News 4 Ethylene Oxide in Southeastern Louisiana's Petrochemical Corridor: High Spatial Resolution Mobile Monitoring during HAP-MAP—Environmental Science and Technology Surprisingly High Levels of Toxic Gas Found in Lousiana—The Hub Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

A patent foramen ovale (PFO) is present in approximately 25% of all adults. Author David M. Kent, MD, MS, of Tufts Medical Center and JAMA Associate Editor David Simel, MD, MHS, discuss how to evaluate the likelihood that a PFO was causal in a patient with a cryptogenic ischemic stroke, and closure of a PFO to lower the incidence of recurrent strokes for affected patients. Related Content: Patent Foramen Ovale and Stroke Patent Foramen Ovale and Dysarthria in a Man in His 60s Management of Patients With a Patent Foramen Ovale With History of Stroke or TIA Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke Transesophageal Echocardiogram Detecting a High-Risk Patent Foramen Ovale ----------------------------------- JAMA Editors' Summary